| |||||||||
Former Names STOCK Ppidtm1.1Mmos/J (Changed: 21-AUG-08 ) Type Mutant Stock; Targeted Mutation; Additional information on Genetically Engineered Mutant Mice. Species laboratory mouse Donating Investigator Stanley Korsmeyer, Dana-Farber Cancer Institute Description
Mice that are homozygous for the targeted mutation are viable, fertile, normal in size and do not display any gross physical or behavioral abnormalities. Brain architecture and cerebrovasculature are normal. No gene product (protein) is detected by immunoblot analysis of mitochondria isolated from liver tissue of mutant mice. Mitochondria from mutant mice have an increased capacity to retain calcium and fail to swell/rupture in response to CaCl2, suggesting abnormal permeability transition pore (PTP) function. Mouse embryonic fibroblasts (MEFs) derived from mutant mice are less susceptible to oxidative stress induced in vitro by exposure to hydrogen peroxide than MEFs derived from wildtype mice. In a model of ischemic brain injury employing a middle cerebral artery occlusion protocol, mutant mice exhibited a reduced infarct volume (37% in heterozygotes, and 62% in homozygotes) when compared to wildtype mice. This mutant mouse strain may be useful in studies investigating oxidative stress- and ischemia–induced cell death.Development
A targeting vector containing a loxP-flanked neomycin resistance gene cassette preceding exons 3-5 and a third loxP site downstream of exon 5 was electroporated into 129X1/SvJ-derived RW4 embryonic stem (ES) cells. Correctly targeted ES cells were transiently transfected with a pMC-Cre gene to delete the neo gene (resulting in loxP-flanked exons 3-5 [CypDflox]) and then injected into C57BL/6 blastocysts. Chimeric mice were crossed to C57BL/6. The resulting heterozygotes were next crossed to FVB/N-Tg(EIIa-cre)C5379Lmgd/J (Stock No. 003314). Mice having been recombined such that exons 3-5 are replaced with a single loxP site (CypDnull) were intercrossed to generate mice homozygous for the deletion.
| Control | ||
|---|---|---|
| 101045 B6129SF2/J | (approximate) | |
| Considerations for Choosing Controls | ||
Strains carrying other alleles of Ppif
005737 STOCK Ppiftm1Mmos/J View Strains carrying other alleles of Ppif (1 strain)
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
Ppiftm1.1Mmos/Ppid+
involves: 129X1/SvJ * FVB/NJ
- nervous system phenotype
- decreased cerebral infarction size (MGI Ref ID J:101149)
- infarct volume induced by middle cerebral artery occlusion is reduced by 37% in heterozygotes relative to wild-type siblings
- homeostasis/metabolism phenotype
- decreased cerebral infarction size (MGI Ref ID J:101149)
- infarct volume induced by middle cerebral artery occlusion is reduced by 37% in heterozygotes relative to wild-type siblings
Ppiftm1.1Mmos/Ppiftm1.1Mmos
involves: 129X1/SvJ * FVB/NJ
- cellular phenotype
- abnormal mitochondrial physiology (MGI Ref ID J:101149)
- cultured embryonic fibroblasts from homozygotes are less susceptible to H2O2 induced cell death but respond normally to etoposide, staurosporine, thapsigargin, tunicamycin, brefeldin A, tumor necrosis factor alpha and TNFSF10
- 100uM CaCl2 fails to induce mitochondiral swelling in mitochondria from homozygous liver
- nervous system phenotype
- *normal* nervous system phenotype (MGI Ref ID J:101149)
- normal brain and cerebrovasculature
- decreased cerebral infarction size (MGI Ref ID J:101149)
- infarct volume induced by middle cerebral artery occlusion is reduced by 62% in homozygotes relative to wild-type siblings
- homeostasis/metabolism phenotype
- decreased cerebral infarction size (MGI Ref ID J:101149)
- infarct volume induced by middle cerebral artery occlusion is reduced by 62% in homozygotes relative to wild-type siblings
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:
Cell Biology Research
Channel and Transporter Defects (calcium)
Metabolism Research
Free Radical Research
Research Tools
Apoptosis Research
Cell Biology Research
Metabolism Research
| Allele Symbol | Ppiftm1.1Mmos | ||
|---|---|---|---|
| Allele Name | targeted mutation 1.1, Michael A Moskowitz | ||
| Allele Type | Targeted (knock-out) | ||
| Common Name(s) | CypDnull; | ||
| Mutation Made By | Stanley Korsmeyer, Dana-Farber Cancer Institute | ||
| Strain of Origin | 129X1/SvJ | ||
| ES Cell Line Name | RW-4 | ||
| ES Cell Line Strain | 129X1/SvJ | ||
| Gene Symbol and Name | Ppif, peptidylprolyl isomerase F (cyclophilin F) | ||
| Chromosome | 14 | ||
| Gene Common Name(s) | AW457192; CYP3; CyP-D; CyP-F; CypD; FLJ90798; MGC117207; MGC93084; PPIase; expressed sequence AW457192; mitochondrial Cyclophilin D; | ||
| Molecular Note | A targeting vector was designed to insert loxP sites around exons 3-5. Crossing with mice expressing cre in the germ line resulted in a null allele, as was demonstrated by immunoblot of liver samples. [MGI Ref ID J:101149] | ||
Genotyping Protocols
Ppiftm1.1Mmos, STD PCR, vers. 1
Helpful Links
Optimizing PCR Protocols
Schinzel AC; Takeuchi O; Huang Z; Fisher JK; Zhou Z; Rubens J; Hetz C; Danial NN; Moskowitz MA; Korsmeyer SJ. 2005. Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc Natl Acad Sci U S A 102(34):12005-10. [PubMed: 16103352] [MGI Ref ID J:101149]
Colony Maintenance
Breeding & Husbandry When maintaining a live colony, these mice are bred as homozygotes.
| Pricing for USA, Canada and Mexico shipping destinations |
|
*Price(s) in US dollars ($)
Weeks of Age Price* Gender Cryorecovery Fee $1900.00 Cryopreserved Embryos Fee $1600.00
| Pricing for International shipping destinations |
|
*Price(s) in US dollars ($)
Weeks of Age Price* Gender Cryorecovery Fee $2470.00 Cryopreserved Embryos Fee $2080.00
| Standard Supply | Repository-Cryopreserved. Must Be Recovered. Please refer to pricing and supply notes for further information. |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| 101045 B6129SF2/J | (approximate) | |
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form
For additional Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. THE LABORATORY EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of MICE, products or services, The Jackson Laboratory will, at its option, provide credit or replacement for the MICE or product received or the services provided.
In no event shall The Jackson Laboratory, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, products or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of The Jackson Laboratory, its agents or employees. In purchasing or receiving MICE, products or services from The Jackson Laboratory, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges The Jackson Laboratory from all such causes of action or damages, and further agrees to defend and indemnify The Jackson Laboratory from any costs or damages arising out of any third party claims.
MICE and biological materials are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to The Jackson Laboratory’s MICE, products and services. In addition, special terms and conditions of sale of certain MICE, products and services may be set forth separately in The Jackson Laboratory web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, products and services by The Jackson Laboratory, and by its licensees and distributors.
Acceptance of delivery of MICE, products or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on The Jackson Laboratory, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, products services by The Jackson Laboratory.